BIOTRONIK Announces Completion of Enrollment in IMPACT Study to Investigate Stroke Risk Reduction in Patients With Atrial Fibrillation

IMPACT Study Evaluates the Use of BIOTRONIK Home Monitoring(R) for Early Detection of Atrial Fibrillation, Combined With an Anticoagulation Plan for Stroke Risk Reduction BERLIN–(Marketwired / Asianet-Pakistan – May 23, 2013) –  BIOTRONIK, a leading manufacturer of innovative medical technology, announced today that enrollment has been completed for the highly anticipated IMPACT study. The study […]Read More

Read more